Illumina January 16, 2026 Fierce Pharma Asia—AbbVie’s bispecific play, Illumina’s China import efforts and pharma execs’ JPM comments - Fierce Pharma This article's full content could not be retrieved due to source site restrictions. Read full story on Illumina